COMMISSION IMPLEMENTING REGULATION (EU) 2023/114 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, buprofezin, cyflufenamid, fluazinam, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metiram, metsulfuron-methyl, phosphane and pyraclostrobin ANNEX

Changelog

0 versions

Article-level history is being prepared

The official source publishes these consolidated versions; article-by-article changes will appear here as soon as they are processed.

No consolidated versions are recorded for this law.